Maravai LifeSciences, Inc. announced plans for William “Trey” Martin, III to serve as President of Maravai's Biologics Safety Testing Segment beginning December 5, 2022, and Christine Dolan, the current Chief Operating Officer of Maravai's Biologics Safety Testing Segment, will continue to serve in that role and will report to Martin. Carl Hull, Maravai's co-founder, will continue to serve as Maravai's Executive Chairman.